Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Nirsevimab Resistance Mutations Rare in RSV, Study Shows
Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may lead to resistance mutations. However, according to the French POLYRES study on prospective monitoring…
English